Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 692795, 11 pages
http://dx.doi.org/10.1155/2015/692795
Research Article

Effect and Potential Mechanism of Electroacupuncture Add-On Treatment in Patients with Parkinson’s Disease

1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
2Department of Acupuncture, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
3Department of Physiology, Capital Medical University, Beijing 100069, China
4Department of Geriatrics, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
5Key Laboratory for Neurodegenerative Disorders of the Ministry of Education, Beijing 100069, China
6Center of Parkinson’s Disease, Beijing Institute for Brain Disorders, Beijing 100053, China
7China National Clinical Research Center for Neurological Diseases, Beijing 100050, China
8Beijing Key Laboratory on Parkinson’s Disease, Beijing 100053, China

Received 15 March 2015; Accepted 28 July 2015

Academic Editor: Andreas Sandner-Kiesling

Copyright © 2015 Fang Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. D. Dick, G. De Palma, A. Ahmadi et al., “Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study,” Occupational and Environmental Medicine, vol. 64, no. 10, pp. 666–672, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Braak, K. del Tredici, U. Rüb, R. A. I. de Vos, E. N. H. Jansen Steur, and E. Braak, “Staging of brain pathology related to sporadic Parkinson's disease,” Neurobiology of Aging, vol. 24, no. 2, pp. 197–211, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Gallagher, A. J. Lees, and A. Schrag, “What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?” Movement Disorders, vol. 25, no. 15, pp. 2493–2500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. E. M. Khedr, N. A. El Fetoh, H. Khalifa, M. A. Ahmed, and K. M. A. El Beh, “Prevalence of non motor features in a cohort of Parkinson's disease patients,” Clinical Neurology and Neurosurgery, vol. 115, no. 6, pp. 673–677, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Nègre-Pagès, H. Grandjean, M. Lapeyre-Mestre et al., “Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPAMiP study,” Movement Disorders, vol. 25, no. 2, pp. 157–166, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Degardin, E. Houdayer, J.-L. Bourriez et al., “Deficient ‘sensory’ beta synchronization in Parkinson's disease,” Clinical Neurophysiology, vol. 120, no. 3, pp. 636–642, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. E. C. Schulte and J. Winkelmann, “When Parkinson's disease patients go to sleep: specific sleep disturbances related to Parkinson's disease,” Journal of Neurology, vol. 258, supplement 2, pp. S328–S335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. T. K. Khoo, A. J. Yarnall, G. W. Duncan et al., “The spectrum of nonmotor symptoms in early Parkinson disease,” Neurology, vol. 80, no. 3, pp. 276–281, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Stowe, N. Ives, C. E. Clarke et al., “Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications,” Cochrane Database of Systematic Reviews, no. 7, Article ID CD007166, 2010. View at Google Scholar · View at Scopus
  10. C. L. Tomlinson, R. Stowe, S. Patel, C. Rick, R. Gray, and C. E. Clarke, “Systematic review of levodopa dose equivalency reporting in Parkinson's disease,” Movement Disorders, vol. 25, no. 15, pp. 2649–2653, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Poewe, “Treatments for Parkinson disease—past achievements and current clinical needs,” Neurology, vol. 72, no. 7, supplement, pp. S65–S73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Yan, M. Sun, Y. Zhou et al., “Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model,” PLoS ONE, vol. 8, no. 5, Article ID e64000, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Cristian, M. Katz, E. Cutrone, and R. H. Walker, “Evaluation of acupuncture in the treatment of Parkinson's disease: a double-blind pilot study,” Movement Disorders, vol. 20, no. 9, pp. 1185–1188, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Xia, H.-D. Wang, Y. Ding, B. Kang, and W.-G. Liu, “Parkinson's disease combined with depression treated with electroacupuncture and medication and its effect on serum BDNF,” Chinese Acupuncture & Moxibustion, vol. 32, no. 12, pp. 1071–1074, 2012. View at Google Scholar · View at Scopus
  15. D. V. Arankalle and P. M. K. Nair, “Effect of electroacupuncture on function and quality of life in Parkinson's disease: a case report,” Acupuncture in Medicine, vol. 31, no. 2, pp. 235–238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Wang, Y. Pan, B. Xue et al., “The antioxidative effect of electro-acupuncture in a mouse model of Parkinson's disease,” PLoS ONE, vol. 6, no. 5, Article ID e19790, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. X.-J. Qi and S. Wang, “Effects of penetration therapy with scalp electroacupuncture on gene expressions of nerve growth factors in substantia nigra of rats with Parkinson's disease,” Chinese Acupuncture & Moxibustion, vol. 31, no. 5, pp. 435–440, 2011. View at Google Scholar · View at Scopus
  18. J. M. Kang, H. J. Park, Y. G. Choi et al., “Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model,” Brain Research, vol. 1131, no. 1, pp. 211–219, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. L.-R. Huo, X.-B. Liang, B. Li et al., “The cortical and striatal gene expression profile of 100 Hz electroacupuncture treatment in 6-hydroxydopamine-induced Parkinson's disease model,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 908439, 13 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. S.-Y. Cho, S.-R. Shim, H. Y. Rhee et al., “Effectiveness of acupuncture and bee venom acupuncture in idiopathic Parkinson's disease,” Parkinsonism & Related Disorders, vol. 18, no. 8, pp. 948–952, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. B.-Y. Zeng, S. Salvage, and P. Jenner, “Current development of acupuncture research in Parkinson's disease,” International Review of Neurobiology, vol. 111, pp. 141–158, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. D. R. Rajput, “Accuracy of clinical diagnosis of idiopathic Parkinson's disease,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 56, no. 8, pp. 938–939, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Schrag, M. Jahanshahi, and N. Quinn, “What contributes to quality of life in patients with Parkinson's disease?” Journal of Neurology Neurosurgery and Psychiatry, vol. 69, no. 3, pp. 308–312, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. L. M. Shulman, X. Wen, W. J. Weiner et al., “Acupuncture therapy for the symptoms of Parkinson's disease,” Movement Disorders, vol. 17, no. 4, pp. 799–802, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Huang, X. Jiang, Y. Zhuo, and G. Wik, “Complementary acupuncture in Parkinson's disease: a spect study,” The International Journal of Neuroscience, vol. 120, no. 2, pp. 150–154, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Jia, B. Li, Z.-L. Sun, F. Yu, X. Wang, and X.-M. Wang, “Electro-acupuncture stimulation acts on the basal ganglia output pathway to ameliorate motor impairment in Parkinsonian model rats,” Behavioral Neuroscience, vol. 124, no. 2, pp. 305–310, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. F.-W. Zhou, S. G. Matta, and F.-M. Zhou, “Constitutively active TRPC3 channels regulate basal ganglia output neurons,” The Journal of Neuroscience, vol. 28, no. 2, pp. 473–482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Huang, X. Jiang, Y. Zhuo, A. Tang, and G. Wik, “Complementary acupuncture treatment increases cerebral metabolism in patients with parkinson's disease,” The International Journal of Neuroscience, vol. 119, no. 8, pp. 1190–1197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Yeo, S. Lim, I.-H. Choe et al., “Acupuncture stimulation on GB34 activates neural responses associated with parkinson's disease,” CNS Neuroscience & Therapeutics, vol. 18, no. 9, pp. 781–790, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Pintor, E. Baillès, F. Valldeoriola, E. Tolosa, M. J. Martí, and J. de Pablo, “Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode,” General Hospital Psychiatry, vol. 28, no. 1, pp. 59–64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. N. J. Diederich and D. J. McIntyre, “Sleep disorders in Parkinson's disease: many causes, few therapeutic options,” Journal of the Neurological Sciences, vol. 314, no. 1-2, pp. 12–19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. D. B. Rye, “The two faces of Eve: dopamine's modulation of wakefulness and sleep,” Neurology, vol. 63, no. 8, supplement 3, pp. S2–S7, 2004. View at Google Scholar · View at Scopus
  33. B. S. Lu and P. C. Zee, “Neurobiology of sleep,” Clinics in Chest Medicine, vol. 31, no. 2, pp. 309–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Hood, P. Cassidy, M.-P. Cossette et al., “Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors,” The Journal of Neuroscience, vol. 30, no. 42, pp. 14046–14058, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Huang, N. Kutner, and D. L. Bliwise, “A systematic review of the effects of acupuncture in treating insomnia,” Sleep Medicine Reviews, vol. 13, no. 1, pp. 73–104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. D. W. Spence, L. Kayumov, A. Chen et al., “Acupuncture increases nocturnal melatonin secretion and reduces insomnia and anxiety: a preliminary report,” The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 16, no. 1, pp. 19–28, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. M. L. Block, L. Zecca, and J.-S. Hong, “Microglia-mediated neurotoxicity: uncovering the molecular mechanisms,” Nature Reviews Neuroscience, vol. 8, no. 1, pp. 57–69, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. L. Block and J.-S. Hong, “Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism,” Progress in Neurobiology, vol. 76, no. 2, pp. 77–98, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Zhang, K. Phillips, A. R. Wielgus et al., “Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease,” Neurotoxicity Research, vol. 19, no. 1, pp. 63–72, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. C. J. Barnum and M. G. Tansey, “Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?” Current Neurology and Neuroscience Reports, vol. 12, no. 4, pp. 350–358, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Lindqvist, S. Hall, Y. Surova et al., “Cerebrospinal fluid inflammatory markers in Parkinson's disease—associations with depression, fatigue, and cognitive impairment,” Brain, Behavior, and Immunity, vol. 33, pp. 183–189, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Kouti, M. Noroozian, S. Akhondzadeh et al., “Nitric oxide and peroxynitrite serum levels in Parkinson's disease: correlation of oxidative stress and the severity of the disease,” European Review for Medical and Pharmacological Sciences, vol. 17, no. 7, pp. 964–970, 2013. View at Google Scholar · View at Scopus
  43. D. Tuncel, T. F. Inanc, and I. Toru, “Serum insulin-like growth factor-1 and nitric oxide levels in Parkinson's disease,” Mediators of Inflammation, vol. 2009, Article ID 132464, 4 pages, 2009. View at Publisher · View at Google Scholar
  44. M. C. Hernández-Romero, M. J. Delgado-Cortés, M. Sarmiento et al., “Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system,” NeuroToxicology, vol. 33, no. 3, pp. 347–360, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. R. F. Villarán, A. M. Espinosa-Oliva, M. Sarmiento et al., “Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson's disease,” Journal of Neurochemistry, vol. 114, no. 6, pp. 1687–1700, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. L. J. Kennedy, K. Moore Jr., J. L. Caulfield, S. R. Tannenbaum, and P. C. Dedon, “Quantitation of 8-oxoguanine and strand breaks produced by four oxidizing agents,” Chemical Research in Toxicology, vol. 10, no. 4, pp. 386–392, 1997. View at Publisher · View at Google Scholar · View at Scopus
  47. A. G. Estévez and J. Jordán, “Nitric oxide and superoxide, a deadly cocktail,” Annals of the New York Academy of Sciences, vol. 962, pp. 207–211, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. D. J. Clarke and R. L. Branton, “A role for tumor necrosis factor α in death of dopaminergic neurons following neural transplantation,” Experimental Neurology, vol. 176, no. 1, pp. 154–162, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Possel, H. Noack, J. Putzke, G. Wolf, and H. Sies, “Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies,” Glia, vol. 32, no. 1, pp. 51–59, 2000. View at Google Scholar · View at Scopus